Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4
Authors:
Open Access
- 8 August 2008
- journal article
- review article
- Published by Wiley in Proteomics
- Vol. 8 (16) , 3360-3370
Abstract
Hepatocyte growth factor (HGF) and Met/HGF receptor tyrosine kinase play a role in the progression to invasive and metastatic cancers. A variety of cancer cells secrete molecules that enhance HGF expression in stromal fibroblasts, while fibroblast‐derived HGF, in turn, is a potent stimulator of the invasion of cancer cells. In addition to the ligand‐dependent activation, Met receptor activation is negatively regulated by cell–cell contact and Ser985 phosphorylation in the juxtamembrane of Met. The loss of intercellular junctions may facilitate an escape from the cell–cell contact‐dependent suppression of Met‐signaling. Significance of juxtamembrane mutations found in human cancers is assumed to be a loss‐of‐function in the negative regulation of Met. In attempts to block the malignant behavior of cancers, NK4 was isolated as a competitive antagonist against HGF–Met signaling. Independently on its HGF‐antagonist action, NK4 inhibited angiogenesis induced by vascular endothelial cell growth factor and basic fibroblast growth factor, as well as HGF. In experimental models of distinct types of cancers, NK4 inhibited Met activation and this was associated with inhibition of tumor invasion and metastasis. NK4 inhibited tumor angiogenesis, thereby suppressing angiogenesis‐dependent tumor growth. Cancer treatment with NK4 suppresses malignant tumors to be “static” in both tumor growth and spreading.Keywords
This publication has 73 references indexed in Scilit:
- Inhibition of colon cancer growth and metastasis by NK4 gene repetitive delivery in miceBiochemical and Biophysical Research Communications, 2007
- MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 SignalingScience, 2007
- Mechanisms and significance of bifunctional NK4 in cancer treatmentBiochemical and Biophysical Research Communications, 2005
- Adenoviral-mediated Gene transduction of the hepatocyte growth factor (HGF) antagonist, NK4, suppresses peritoneal metastases of gastric cancer in nude miceEuropean Journal of Cancer, 2004
- Kringle 1–4 of Hepatocyte Growth Factor Inhibits Proliferation and Migration of Human Microvascular Endothelial CellsBiochemical and Biophysical Research Communications, 2000
- Kringle 1 of Human Hepatocyte Growth Factor Inhibits Bovine Aortic Endothelial Cell Proliferation Stimulated by Basic Fibroblast Growth Factor and Causes Cell ApoptosisBiochemical and Biophysical Research Communications, 2000
- Hepatocyte Growth Factor (HGF) as a Tissue Organizer for Organogenesis and RegenerationBiochemical and Biophysical Research Communications, 1997
- In Vivo Activation ofmetTyrosine Kinase by Heterodimeric Hepatocyte Growth Factor Molecule Promotes AngiogenesisArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factorBiochemical and Biophysical Research Communications, 1989
- Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized ratsBiochemical and Biophysical Research Communications, 1984